DAVID SCHOLL: Open Payments
NPI 1003811886 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,459 in 35 payments from 18 companies in 2025. Trend: 2023 $774 · 2024 $1,138 · 2025 $1,459
Long term medical supply or device loan: $781Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $826 |
| PFIZER INC. | 4 | $98 |
| Daiichi Sankyo Inc. | 3 | $83 |
| Merck Sharp & Dohme LLC | 2 | $58 |
| ABBVIE INC. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Caris MPI, Inc. | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Exelixis Inc. | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $27 |
Products named: KISQALI, Enhertu, KEYTRUDA, VENCLEXTA, LYNPARZA, MI CANCER SEEK, Nubeqa, PADCEV.
Industry payments across GA — which companies pay providers there.
